nach oben

Erschienen in:

01.03.2013 | Original Contribution

A moderate weight reduction through dietary intervention decreases hepatic fat content in patients with non-alcoholic fatty liver disease (NAFLD): a pilot study

verfasst von: Valentina Volynets, Jürgen Machann, Markus A. Küper, Ina B. Maier, Astrid Spruss, Alfred Königsrainer, Stephan C. Bischoff, Ina Bergheim

Erschienen in: European Journal of Nutrition | Ausgabe 2/2013

Einloggen, um Zugang zu erhalten

Abstract

Purpose

As a diet rich in fructose and an impaired intestinal barrier function have been proposed to be risk factors for the development of non-alcoholic fatty liver disease (NAFLD), the aim of the present pilot study was to determine whether a dietary intervention focusing on a reduction of fructose intake (−50 % in comparison with baseline) has a beneficial effect on liver status.

Methods

A total of 15 patients with NAFLD were enrolled in the study of which 10 finished the study. Fructose and total nutrient intake were assessed using a diet history. At baseline and after 6 months liver status and markers of intestinal barrier function as well as plasminogen activator inhibitor (PAI-) 1 concentration were determined in plasma.

Results

Hepatic lipid content and transaminases in plasma as well as body mass index and some parameters of glucose metabolism (e.g., fasting plasma insulin) were significantly lower at the end of the intervention when compared to baseline. Whereas the dietary intervention had no effect on the prevalence of bacterial overgrowth, orocecal transit time and the intestinal permeability or blood ethanol levels endotoxin and PAI-1 concentration in plasma were significantly lower at the end of 6 months intervention period than at baseline.

Conclusions

Taken together, our results indicate that a dietary intervention focusing only on one dietary parameter like fructose may help to decrease intrahepatic fat content of NAFLD patients.

Nur mit Berechtigung zugänglich

Thuy S, Ladurner R, Volynets V, Wagner S, Stahl S, Königsrainer A et al (2008) Nonalcoholic fatty liver disease in humans is associated with increased plasma endotoxin and plasminogen activator inhibitor 1 concentrations and with fructose intake. J Nutr 138:1452–1455

Wigg AJ, Roberts-Thomson IC, Dymock RB, McCarthy PJ, Grose RH, Cummins AG (2001) The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis. Gut 48:206–211CrossRef

Soza A, Riquelme A, Gonzalez R, Alvarez M, Perez-Ayuso RM, Glasinovic JC et al (2005) Increased orocecal transit time in patients with nonalcoholic fatty liver disease. Dig Dis Sci 50:1136–1140CrossRef

Miele L, Valenza V, La Torre G, Montalto M, Cammarota G, Ricci R et al (2009) Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease. Hepatology 49:1877–1887CrossRef

Farhadi A, Gundlapalli S, Shaikh M, Frantzides C, Harrell L, Kwasny MM et al (2008) Susceptibility to gut leakiness: a possible mechanism for endotoxaemia in non-alcoholic steatohepatitis. Liver Int 28:1026–1033CrossRef

Nair S, Cope K, Risby TH, Diehl AM (2001) Obesity and female gender increase breath ethanol concentration: potential implications for the pathogenesis of nonalcoholic steatohepatitis. Am J Gastroenterol 96:1200–1204CrossRef

Ouyang X, Cirillo P, Sautin Y, McCall S, Bruchette JL, Diehl AM et al (2008) Fructose consumption as a risk factor for non-alcoholic fatty liver disease. J Hepatol 48:993–999CrossRef

Assy N, Nasser G, Kamayse I, Nseir W, Beniashvili Z, Djibre A et al (2008) Soft drink consumption linked with fatty liver in the absence of traditional risk factors. Can J Gastroenterol 22:811–816

Abdelmalek MF, Suzuki A, Guy C, Unalp-Arida A, Colvin R, Johnson RJ et al (2010) Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease. Hepatology 51:1961–1971CrossRef

10.

Ackerman Z, Oron-Herman M, Grozovski M, Rosenthal T, Pappo O, Link G et al (2005) Fructose-induced fatty liver disease: hepatic effects of blood pressure and plasma triglyceride reduction. Hypertension 45:1012–1018CrossRef

11.

Bergheim I, Weber S, Vos M, Krämer S, Volynets V, Kaserouni S et al (2008) Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: role of endotoxin. J Hepatol 48:983–992CrossRef

12.

Haub S, Kanuri G, Volynets V, Brune T, Bischoff SC, Bergheim I (2010) Serotonin reuptake transporter (SERT) plays a critical role in the onset of fructose-induced hepatic steatosis in mice. Am J Physiol Gastrointest Liver Physiol 298:G335–G344CrossRef

13.

Kanuri G, Spruss A, Wagnerberger S, Bischoff SC, Bergheim I (2011) Fructose-induced steatosis in mice: role of plasminogen activator inhibitor-1 (PAI-1), microsomal triglyceride transfer protein (MTTP) and NKT cells. Lab Invest 91:885–895CrossRef

14.

Spruss A, Kanuri G, Wagnerberger S, Haub S, Bischoff SC, Bergheim I (2009) Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice. Hepatology 50:1094–1104CrossRef

15.

Volynets V, Spruss A, Kanuri G, Wagnerberger S, Bischoff SC, Bergheim I (2010) Protective effect of bile acids on the onset of fructose-induced hepatic steatosis in mice. J Lipid Res 51:3414–3424CrossRef

16.

Machann J, Thamer C, Schnoedt B, Haap M, Haring HU, Claussen CD et al (2005) Standardized assessment of whole body adipose tissue topography by MRI. J Magn Reson Imaging 21:455–462CrossRef

17.

Machann J, Thamer C, Schnoedt B, Stefan N, Haring HU, Claussen CD et al (2006) Hepatic lipid accumulation in healthy subjects: a comparative study using spectral fat-selective MRI and volume-localized 1H-MR spectroscopy. Magn Reson Med 55:913–917CrossRef

18.

Landig J, Erhardt JG, Bode JC, Bode C (1998) Validation and comparison of two computerized methods of obtaining a diet history. Clin Nutr 17:113–117CrossRef

19.

Generoso M, De Rosa M, De Rosa R, De Magistris L, Secondulfo M, Fiandra R et al (2003) Cellobiose and lactulose coupled with mannitol and determined using ion-exchange chromatography with pulsed amperometric detection, are reliable probes for investigation of intestinal permeability. J Chromatogr B Analyt Technol Biomed Life Sci 783:349–357CrossRef

20.

Cariello R, Federico A, Sapone A, Tuccillo C, Scialdone VR, Tiso A et al (2010) Intestinal permeability in patients with chronic liver diseases: Its relationship with the aetiology and the entity of liver damage. Dig Liver Dis 42:200–204CrossRef

21.

Bonnichsen RK, Theorell H (1951) An enzymatic method for the microdetermination of ethanol. Scand J Clin Lab Invest 3:58–62CrossRef

22.

Parlesak A, Klein B, Schecher K, Bode JC, Bode C (2003) Prevalence of small bowel bacterial overgrowth and its association with nutrition intake in nonhospitalized older adults. J Am Geriatr Soc 51:768–773CrossRef

23.

La Brooy SJ, Male PJ, Beavis AK, Misiewicz JJ (1983) Assessment of the reproducibility of the lactulose H2 breath test as a measure of mouth to caecum transit time. Gut 24:893–896CrossRef

24.

York LW, Puthalapattu S, Wu GY (2009) Nonalcoholic fatty liver disease and low-carbohydrate diets. Annu Rev Nutr 29:365–379CrossRef

25.

Centis E, Marzocchi R, Di Domizio S, Ciaravella MF, Marchesini G (2010) The effect of lifestyle changes in non-alcoholic fatty liver disease. Dig Dis Sci 28:267–273CrossRef

26.

Thoma C, Day CP, Trenell MI (2011) Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: a systematic review. J Hepat. doi:10.1016j.jhep.2011.06.010

27.

Parlesak A, Bode JC, Bode C (1994) Parallel determination of gut permeability in man with M(r) 400, M(r) 1500, M(r) 4000 and M(r) 10,000 polyethylene glycol. Eur J Clin Chem Clin Biochem 32:813–820

28.

Baffy G (2009) Kupffer cells in non-alcoholic fatty liver disease: the emerging view. J Hepatol 51:212–223CrossRef

29.

Golay A, Eigenheer C, Morel Y, Kujawski P, Lehmann T, de Tonnac C (1996) Weight-loss with low or high carbohydrate diet? Int J Obes Relat Metab Disord 20:1067–1072

30.

Huang MA, Greenson JK, Chao C, Anderson L, Peterman D, Jacobson J et al (2005) One-year intense nutritional counseling results in histological improvement in patients with non-alcoholic steatohepatitis: a pilot study. Am J Gastroenterol 100:1072–1081CrossRef

31.

Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419CrossRef

Titel: A moderate weight reduction through dietary intervention decreases hepatic fat content in patients with non-alcoholic fatty liver disease (NAFLD): a pilot study
verfasst von: Valentina Volynets
Jürgen Machann
Markus A. Küper
Ina B. Maier
Astrid Spruss
Alfred Königsrainer
Stephan C. Bischoff
Ina Bergheim
Publikationsdatum: 01.03.2013
Verlag: Springer-Verlag
Erschienen in: European Journal of Nutrition / Ausgabe 2/2013
Print ISSN: 1436-6207
Elektronische ISSN: 1436-6215
DOI: https://doi.org/10.1007/s00394-012-0355-z

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

A moderate weight reduction through dietary intervention decreases hepatic fat content in patients with non-alcoholic fatty liver disease (NAFLD): a pilot study